Pfizer GC To Step Down Ahead Of Reshuffling

Law360, New York (December 18, 2013, 3:46 PM EST) -- Pfizer Inc.’s general counsel will step down after roughly five years and not take on a leadership role at one of the new branded lines created by an imminent reshuffling in the company that is scheduled to begin in January, the pharmaceutical giant said Tuesday.

Amy Schulman will step down from the firm’s executive leadership and remain in the company for a transitional period, according to a regulatory filing with the U.S. Securities and Exchange Commission. Pfizer did not explain her move beyond stating that Schulman...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.